Journal of Lipid Research, Vol 31, 45-53, Copyright © 1990 by Lipid Research, Inc.

ARTICLES

Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146- ---gln) variant results in a dominant mode of inheritance

M Smit, P de Knijff, E van der Kooij-Meijs, C Groenendijk, AM van den Maagdenberg, JA Gevers Leuven, AF Stalenhoef, PM Stuyt, RR Frants and LM Havekes
Department of Human Genetics, State University of Leiden, The Netherlands.

As determined by isoelectric focusing, most patients with familial dysbetalipoproteinemia (FD) exhibit the homozygous apolipoprotein (apo) E2E2 phenotype. Only rarely does FD develop in the more common heterozygous phenotypes E3E2 or E4E2. In fact, only 1 to 4% of the E2E2 homozygotes will develop FD. We wondered whether this reduced penetrance of FD in E2E2 homozygotes could be due to additional heterogeneity in the APOE*2 allele. In the literature a number of different mutations causing an E2 isoelectric focusing variant have been described. To study the genetic heterogeneity of the APOE gene, hybridization of enzymatically amplified genomic DNA with mutation- specific oligonucleotide probes was applied. All FD patients (n = 40) with the E2E2 phenotype appeared to be homozygous for the common E2(arg158----cys) mutation. However, all three unrelated patients with the E3E2 phenotype exhibited the rare E2(lys146----gln) mutation due to an A----C substitution at nucleotide position 3,847 of the APOE gene. This mutation was not found among normolipidemic individuals with the E2E2 (n = 13) or E3E2 phenotype (n = 120) selected from a random population sample. Family studies of the three probands heterozygous for the E*2(lys146----gln) allele showed that this rare allele predisposes to FD with high penetrance. We conclude that FD is a genetically heterogeneous disease entity, displaying a recessive mode of inheritance with strongly reduced penetrance in case of the common E2(arg158----cys) variant and with a dominant mode of inheritance with high penetrance in case of the rare E2(lys146----gln) mutant. It should be noted that in this dominant form presymptomatic diagnosis is possible.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				X. Li, H.-Y. Kan, S. Lavrentiadou, M. Krieger, and V. Zannis Reconstituted Discoidal ApoE-Phospholipid Particles Are Ligands for the Scavenger Receptor BI. THE AMINO-TERMINAL 1-165 DOMAIN OF ApoE SUFFICES FOR RECEPTOR BINDING J. Biol. Chem., June 7, 2002; 277(24): 21149 - 21157. [Abstract] [Full Text] [PDF]

				M. Zaiou, K. S. Arnold, Y. M. Newhouse, T. L. Innerarity, K. H. Weisgraber, M. L. Segall, M. C. Phillips, and S. Lund-Katz Apolipoprotein E;-low density lipoprotein receptor interaction: influences of basic residue and amphipathic {alpha}-helix organization in the ligand J. Lipid Res., July 1, 2000; 41(7): 1087 - 1095. [Abstract] [Full Text]

				F. de Beer, K. W. van Dijk, M. C. Jong, L. C. van Vark, A. van der Zee, M. H. Hofker, F. J. Fallaux, R. C. Hoeben, A. H. M. Smelt, and L. M. Havekes Apolipoprotein E2 (Lys146->Gln) Causes Hypertriglyceridemia due to an Apolipoprotein E Variant-Specific Inhibition of Lipolysis of Very Low Density Lipoproteins-Triglycerides Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1800 - 1806. [Abstract] [Full Text] [PDF]

				R. W. Mahley, Y. Huang, and S. C. Rall , Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes J. Lipid Res., November 1, 1999; 40(11): 1933 - 1949. [Abstract] [Full Text]

				W. März, M. M. Hoffmann, H. Scharnagl, E. Fisher, M. Chen, M. Nauck, G. Feussner, and H. Wieland Apolipoprotein E2 (Arg136 -> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia J. Lipid Res., March 1, 1998; 39(3): 658 - 669. [Abstract] [Full Text]

				W. J.S. de Villiers, D. R. van der Westhuyzen, G. A. Coetzee, H. E. Henderson, and A. D. Marais The Apolipoprotein E2(Arg145Cys) Mutation Causes Autosomal Dominant Type III Hyperlipoproteinemia With Incomplete Penetrance Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 865 - 872. [Abstract] [Full Text]

				H. Zhang, P. W. A. Reymer, M.-S. Liu, I. J. Forsythe, B. E. Groenemeyer, J. Frohlich, J. D. Brunzell, J. J. P. Kastelein, M. R. Hayden, and Y. Ma Patients With ApoE3 Deficiency (E2/2, E3/2, and E4/2) Who Manifest With Hyperlipidemia Have Increased Frequency of an Asn 291->Ser Mutation in the Human LPL Gene Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1695 - 1703. [Abstract] [Full Text]

				K. E. Kypreos, K. W. van Dijk, A. van der Zee, L. M. Havekes, and V. I. Zannis Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo. CARBOXYL-TERMINAL REGION 203-299 PROMOTES HEPATIC VERY LOW DENSITY LIPOPROTEIN-TRIGLYCERIDE SECRETION J. Biol. Chem., June 1, 2001; 276(23): 19778 - 19786. [Abstract] [Full Text] [PDF]